Effect of insulin and prednisolone on cyclic nucleotides and phosphoenolpyruvate carboxykinase activity in brown fat and liver of developing rats.
The concentrations of cyclic AMP and cyclic GMP in brown fat and liver of both suckling and adult rats at fixed times after injection of insulin (2.5 U/100 g body weight) or prednisolone (2.5 mg/100 g body weight) were compared with the activity of phosphoenolpyruvate carboxykinase assayed 24 h after the injections. A stimulus that produced an increase in cyclic AMP content also produced an increase in the enzyme activity. If the content of cyclic GMP was also increased there was no rise in phosphoenolpyruvate carboxykinase activity. A rise in the content of cyclic GMP alone was associated with a reduction in the activity of the enzyme. These preliminary results indicate that cyclic AMP could be involved in the induction of phosphoenolpyruvate carboxykinase and that cyclic GMP may somehow be related to its repression. The known differences in the response of phosphoenolpyruvate carboxykinase activity to insulin and prednisolone in different tissues and at different stages of ontogenic development may thus be linked to differences in the responsiveness of enzymes concerned with the metabolism of cyclic nucleotides.
D002001:Adipose Tissue, Brown / Q000201:enzymology*; D000375:Aging; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D004790:Enzyme Induction; D004794:Enzyme Repression; D005260:Female; D007328:Insulin / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology*; D009712:Nucleotides, Cyclic / Q000378:metabolism*; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000378:metabolism*; D011239:Prednisolone / Q000494:pharmacology*; D051381:Rats
D007328:Insulin; D009712:Nucleotides, Cyclic; D011239:Prednisolone; D000242:Cyclic AMP; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D006152:Cyclic GMP